S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
LON:MLVN

Malvern International (MLVN) Share Price, News & Analysis

GBX 20
0.00 (0.00%)
(As of 04/19/2024 ET)
Today's Range
20
20
50-Day Range
20
27.50
52-Week Range
14.22
30
Volume
18,979 shs
Average Volume
34,869 shs
Market Capitalization
£4.89 million
P/E Ratio
N/A
Dividend Yield
2.96%
Price Target
N/A
MLVN stock logo

About Malvern International Stock (LON:MLVN)

Malvern International Plc provides educational services in the United Kingdom. The company operates Malvern House London; Malvern House Brighton; Language in Action; Communicate School in Manchester; International Study Centres; and Malvern Online Academy. Its colleges offer English language courses, juniors and summer camps, and bespoke group courses; and university pathway programs, such as pre-university, foundation year, year one, graduate diploma, and pre-master's program; and in-sessional and pre-sessional English programs. The company was formerly known as AEC Education plc and changed its name to Malvern International plc in September 2016. Malvern International Plc was incorporated in 2004 and is headquartered in London, the United Kingdom.

MLVN Stock Price History

MLVN Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
FTSE 100 Rises as TUI, Miners Gain
Malvern Intl Regulatory News
Malvern International Plc (MLVN.L)
Malvern International PLC
Pump Track Accelerating In Malvern
TELA Bio Reports Second Quarter 2022 Financial Results
See More Headlines
Receive MLVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Malvern International and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Education & Training Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
117
Year Founded
N/A

Profitability

Net Income
£-1,080,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£12.26 million
Cash Flow
GBX 6.83 per share
Book Value
GBX (15) per share

Miscellaneous

Free Float
N/A
Market Cap
£4.89 million
Optionable
Not Optionable
Beta
0.57
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Richard Christopher Mace (Age 45)
    CEO & Executive Director
    Comp: $110k
  • Mr. Daniel Ian Fisher (Age 40)
    CFO & Director
    Comp: $82.5k
  • Daniele Pluchino
    Operations Manager
  • Ms. Ashleigh Veres
    Group Head of Sales & Marketing
  • Mr. Emiliano Sallustri
    Head of Juniors & General Manager of Brighton
  • Mr. Stephen Harvey
    Chief Development Officer

MLVN Stock Analysis - Frequently Asked Questions

How have MLVN shares performed in 2024?

Malvern International's stock was trading at GBX 25 at the start of the year. Since then, MLVN stock has decreased by 20.0% and is now trading at GBX 20.
View the best growth stocks for 2024 here
.

When did Malvern International's stock split?

Shares of Malvern International reverse split on the morning of Wednesday, November 2nd 2022. The 1-100 reverse split was announced on Wednesday, November 2nd 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 2nd 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What other stocks do shareholders of Malvern International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Malvern International investors own include Inovio Pharmaceuticals (INO), iBio (IBIO), Fastly (FSLY), Emergent BioSolutions (EBS), DocuSign (DOCU), DISH Network (DISH), Datadog (DDOG), Salesforce (CRM), Co-Diagnostics (CODX) and Bio-Rad Laboratories (BIO).

How do I buy shares of Malvern International?

Shares of MLVN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:MLVN) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners